Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

References for PMC Articles for PubMed (Select 21786460)

1.

Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.

Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, Gatell J, Rakhmanova A, Johnson M, Kirk O, Lundgren J; EuroSIDA Study Group.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):262-70. doi: 10.1097/QAI.0b013e3181e9be6b.

PMID:
20700060
2.

Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.

Tuboi SH, Pacheco AG, Harrison LH, Stone RA, May M, Brinkhof MW, Dabis F, Egger M, Nash D, Bangsberg D, Braitstein P, Yiannoutsos CT, Wood R, Sprinz E, Schechter M; ARTLINC of IeDEA.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):70-7. doi: 10.1097/QAI.0b013e3181c22d19.

3.

Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression.

Falster K, Petoumenos K, Chuah J, Mijch A, Mulhall B, Kelly M, Cooper DA; Australian HIV Observational Database.

J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):307-13. doi: 10.1097/QAI.0b013e3181945ed4.

4.

Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.

Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, Kaslow RA, Kempf MC.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):553-8. doi: 10.1097/QAI.0b013e31816856c5.

PMID:
18285713
5.

Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.

Tuboi SH, Brinkhof MW, Egger M, Stone RA, Braitstein P, Nash D, Sprinz E, Dabis F, Harrison LH, Schechter M.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):52-9.

PMID:
17460471
6.

Discordant immunological and virological responses to antiretroviral therapy.

Schechter M, Tuboi SH.

J Antimicrob Chemother. 2006 Sep;58(3):506-10. Epub 2006 Jul 19.

7.

Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.

Moore DM, Hogg RS, Yip B, Wood E, Tyndall M, Braitstein P, Montaner JS.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):288-93.

PMID:
16249702
8.

The TREAT Asia HIV Observational Database: baseline and retrospective data.

Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG; TREAT Asia HIV Observational Database.

J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):174-9.

9.

Rates of combination antiretroviral treatment change in Australia, 1997-2000.

Australian HIV Observational Database.

HIV Med. 2002 Jan;3(1):28-36.

PMID:
12059948
10.

Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine MD, Costagliola D, Weiss L.

Ann Intern Med. 2000 Sep 19;133(6):401-10.

PMID:
10975957
11.

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease.

Piketty C, Castiel P, Belec L, Batisse D, Si Mohamed A, Gilquin J, Gonzalez-Canali G, Jayle D, Karmochkine M, Weiss L, Aboulker JP, Kazatchkine MD.

AIDS. 1998 May 7;12(7):745-50.

PMID:
9619806
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk